Álvarez-García María Teresa, Fuente-García Carlota, Muñoz-Puyol Cristina, Piñero David P
Vissum Miranza Madrid, Madrid, Spain.
Department of Optics, Pharmacology and Anatomy, University of Alicante, Alicante, Spain.
J Ophthalmol. 2023 Jun 16;2023:8814627. doi: 10.1155/2023/8814627. eCollection 2023.
The purpose of the study is to evaluate the visual and patient-reported outcomes of patients undergoing cataract surgery with implantation of an extended depth of focus (EDOF) intraocular lens (IOL) who were not primarily good candidates for multifocal IOL implantation.
Retrospective analysis of data from 30 eyes (23 patients) undergoing cataract surgery with implantation of one of two EDOF IOLs (follow-up: 37.9 ± 16.2 months) and prospective observational study including 106 eyes (78 patients) implanted with one of 6 different EDOF models (follow-up: 8.0 ± 7.7 months). Patients recruited had one of the following conditions: monofocal IOL implanted in the fellow eye, previous corneal refractive surgery, mild and nonprogressive maculopathy or glaucoma, age > 75 years, amblyopia, or previous vitrectomy.
In the retrospective phase, significant improvements were found in uncorrected distance (UDVA), corrected distance (CDVA), and corrected near visual acuity (CNVA) ( ≤ 0.013), with a nonsignificant trend to improvement in uncorrected near visual acuity (UNVA). A total of 90% of patients were completely to moderately satisfied with the outcome achieved. In the prospective phase, significant improvements were found in UDVA, CDVA, UNVA, and CNVA ( ≤ 0.032), with a total of 85.5% of patients being completely to moderately satisfied (dissatisfaction 3.3%). In both phases, extreme difficulties were only reported by a limited percentage of patients for performing some near vision activities.
EDOF IOLs seem to be a viable option for providing an efficient visual rehabilitation with good levels of patient satisfaction and spectacle independence associated in patients that are not primarily good candidates for multifocal IOL implantation.
本研究旨在评估那些并非多焦点人工晶状体植入主要合适人选的患者,在接受植入扩展景深(EDOF)人工晶状体的白内障手术后的视觉效果及患者报告的结果。
对30只眼(23例患者)接受白内障手术并植入两种EDOF人工晶状体之一的数据进行回顾性分析(随访时间:37.9±16.2个月),以及对106只眼(78例患者)植入6种不同EDOF型号之一的前瞻性观察性研究(随访时间:8.0±7.7个月)。招募的患者有以下情况之一:对侧眼植入单焦点人工晶状体、既往有角膜屈光手术史、轻度且非进行性黄斑病变或青光眼、年龄>75岁、弱视或既往有玻璃体切除术史。
在回顾性阶段,未矫正远视力(UDVA)、矫正远视力(CDVA)和矫正近视力(CNVA)有显著改善(≤0.013),未矫正近视力(UNVA)有不显著的改善趋势。共有90%的患者对所取得的结果完全或中度满意。在前瞻性阶段,UDVA、CDVA、UNVA和CNVA有显著改善(≤0.032),共有85.55%的患者完全或中度满意(不满意率为3.3%)。在两个阶段,只有有限比例的患者报告在进行一些近视力活动时有极大困难。
对于那些并非多焦点人工晶状体植入主要合适人选的患者,EDOF人工晶状体似乎是一种可行的选择,可提供有效的视觉康复,患者满意度高且无需依赖眼镜。